Pfizer (PFE) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.77
- Estimate
- $0.68
- Surprise
- +12.9%
- Revenue (period 2026-06-28)
- $15.03B
- Score at report (before → after)
- 5.6 → 5.5/10
Revenue source: xbrl.
How the report landed
Pfizer (PFE) beat the $0.68 estimate with diluted EPS of $0.77 — a large 12.9% upside surprise. TrendMatrix's engine moved from Hold (5.6/10) to Buy (Wait) at 5.5/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates PFE Hold at 5.4/10.
4 of the last 4 quarters beat the estimate; this quarter's +12.9% surprise compares with a +17.6% four-quarter average. Next scheduled report: 2026-11-03.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Product: top-12 products (65.0%)
- Analyst target reached - limited upside remaining
- Near 52-week high (2.6% away)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $28.44
- Price target
- $32.72
- Stop
- $27.21
- Upside to target
- +15.0%
The stock trades at 37.4× trailing but 9.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-05 — shown for context, not personalized investment advice.
PFE at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - General
- Market cap
- $162.16B
- P/E (fwd)
- 9.8
- P/E (ttm)
- 37.4
- 52-week range
- $23.58–$29.21
- Off 52-week high
- 2.6%
- RSI (14)
- 66
- Volume vs avg
- 0.68×
- Score today
- 5.4/10